Transcripts
Sanofi SA to Discuss Phase 2b Results Of The Investigational BTK Inhibitor ('168) In Relapsing Multiple Sclerosis Conference Call Transcript
2020-04-23Conference Presentations
Read the full earnings transcript with Waltermetrics Pro
The complete transcript text is available to Pro members.
Upgrade to Pro